Literature DB >> 462812

Inhibition of vaccinia virus late protein synthesis by isatin-beta-thiosemicarbazone: characterization and in vitro translation of viral mRNA.

J A Cooper, B Moss, E Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 462812     DOI： 10.1016/0042-6822(79)90096-5

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  6 in total

1.  Regulation of expression and nucleotide sequence of a late vaccinia virus gene.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

2.  Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus.

Authors:  R J Cohrs; R C Condit; R F Pacha; C L Thompson; O K Sharma
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Preferential inhibition of ribonucleic acid synthesis by a new thiosemicarbazone possessing antibacterial and antiparasitic properties.

Authors:  R E Brown; F A Stancato; A D Wolfe
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA.

Authors:  R F Pacha; R C Condit
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

5.  N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo.

Authors:  Liba Sebastian; Anita Desai; Madhusudana N Shampur; Yogeeswari Perumal; D Sriram; Ravi Vasanthapuram
Journal:  Virol J       Date:  2008-05-22       Impact factor: 4.099

6.  Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives.

Authors:  Samir Y Abbas; Awatef A Farag; Yousry A Ammar; Abeer A Atrees; Aly F Mohamed; Ahmed A El-Henawy
Journal:  Monatsh Chem       Date:  2013-07-12       Impact factor: 1.451
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.